Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrinogen polymorphisms and disease

M A Laffan

    European Heart Journal
    |December 1, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ADAMTS-13 glycans and conformation-dependent activity.

    Journal of thrombosis and haemostasis : JTH·2017
    Same author

    A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

    Scientific reports·2016
    Same author

    Von Willebrand factor and angiogenesis: basic and applied issues.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Site-specific analysis of von Willebrand factor O-glycosylation.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    The O-linked glycans of human von Willebrand factor modulate its interaction with ADAMTS-13.

    Journal of thrombosis and haemostasis : JTH·2014
    Same author

    The von Willebrand factor predicted unpaired cysteines are essential for secretion.

    Journal of thrombosis and haemostasis : JTH·2013
    Same journal

    The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

    European heart journal·2026
    Same journal

    Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

    European heart journal·2026
    Same journal

    Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

    European heart journal·2026
    Same journal

    Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

    European heart journal·2026
    Same journal

    Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

    European heart journal·2026
    Same journal

    Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

    European heart journal·2026
    See all related articles